You are here

PHOENIX PHARMALABS, INC.

Company Information
Address
1753 S REDWOOD RD
WOODS CROSS, UT 84087-2316
United States



Information

UEI: SK3VX5DEN6E7

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Identification of Mixed NOP/mu partial agonists as lead compounds for treatment ofmethamphetamine use disorder

    Amount: $319,983.00

    Abstract Currently, clinically used drug abuse medications exist for treatment of addiction to opiates, alcohol, and nicotine, but not psychostimulants, such as methamphetamine (METH). Compounds that ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  2. The Kappa Partial Agonist PPL-103 as a Potential Cocaine Abuse Pharmacotherapy

    Amount: $186,687.00

    Abstract Currentlyclinically used drug abuse medications exist for treatment of addiction to opiatesalcoholand nicotinebut not cocaineThe objective of the proposed project is to test the hypothesis th ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  3. Unique Opioid Analgesics With No Addiction Liability or Dysphoria

    Amount: $200,000.00

    DESCRIPTION (provided by applicant): This Phase I application requests funds to support the continued preclinical evaluation of a novel opioid analgesic, PPL-103, and the synthesis and initial pre ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
  4. A Safe Analgesic Drug with Addiction Treatment Potential

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): This SBIR grant is sought for the purpose of commercializing a promising and needed drug NIH 10497(D-1). It is a novel, orally active opioid with a unique chiral ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government